Changxing Li

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas”.

Phase 1 dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and anti-tumor activity of FCN-159 in adults with neurofibromatosis type 1-related unresectable plexiform neurofibromas

BMC Medicine(2023)10.1186/s12916-023-02927-2

N/A

0.396DataRank · unranked

13 citations

Wenbin Li, Kang Zeng, Zhongyuan Xu, Changxing Li, Zhuang Kang +12 more

Biological Evaluation of the Antibacterial Retinoid CD437 in Cutibacterium acnes Infection

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.01679-22

N/A

0DataRank · unranked

4 citations

Wen Pan, Meizhen Zhong, Yashpal S. Chhonker, Andrew D. Steele, Colleen E. Keohane +8 more